0.4800
0.0000
(0.00%)
At close: April 11 at 4:00:00 PM EDT
0.5299
+0.05
+(10.40%)
After hours: April 11 at 7:38:32 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.41 | -0.36 | -1.38 | 0 |
| Low Estimate | -0.41 | -0.36 | -1.38 | 0 |
| High Estimate | -0.41 | -0.36 | -1.38 | 0 |
| Year Ago EPS | -0.45 | -0.47 | -1.61 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.57 | -0.55 | -0.47 | -0.41 |
| EPS Actual | -0.45 | -0.47 | -0.32 | -0.38 |
| Difference | 0.12 | 0.08 | 0.15 | 0.03 |
| Surprise % | 21.05% | 14.55% | 31.91% | 7.32% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.41 | -0.36 | -1.38 | 0 |
| 7 Days Ago | -0.42 | -0.38 | -1.37 | 0 |
| 30 Days Ago | -0.42 | -0.38 | -1.39 | 0 |
| 60 Days Ago | -0.42 | -0.38 | -1.39 | 0 |
| 90 Days Ago | -0.42 | -0.38 | -1.39 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| INDP | 8.89% | 23.40% | 14.29% | -- |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Upgrades & Downgrades
| Maintains | Maxim Group: Buy to Buy | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/16/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/17/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/15/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/20/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/15/2023 |
Related Tickers
CMMB Chemomab Therapeutics Ltd.
1.0667
+12.00%
PALI Palisade Bio, Inc.
0.6970
+1.87%
QLGN Qualigen Therapeutics, Inc.
3.0000
-0.66%
GOVX GeoVax Labs, Inc.
1.0200
+7.31%
NNVC NanoViricides, Inc.
1.1100
+3.74%
GNTA Genenta Science S.p.A.
3.6500
-2.14%
ACET Adicet Bio, Inc.
0.5370
+20.11%
ASBP Aspire Biopharma Holdings, Inc.
0.5900
+11.32%
IPA ImmunoPrecise Antibodies Ltd.
0.4313
+7.56%
MRSN Mersana Therapeutics, Inc.
0.3109
+18.94%